Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $4.8500 (-3.48%) ($4.8500 - $4.8500) on Fri. Sep. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.23% (three month average) | RSI | 38 | Latest Price | $4.8500(-3.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) SLV(96%) PCY(68%) TIP(54%) TLT(31%) PEJ(19%) | Factors Impacting IOVA price | IOVA will decline at least -2.615% in a week (0% probabilities). LIT(-40%) UUP(-90%) REMX(-47%) ACES(-37%) TBT(-53%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.615% (StdDev 5.23%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.23(-310.93%) | Resistance Level | $5.69 | 5 Day Moving Average | $5.3(-8.49%) | 10 Day Moving Average | $5.36(-9.51%) | 20 Day Moving Average | $5.69(-14.76%) | To recent high | -44.4% | To recent low | 4.4% | Market Cap | $710m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |